Unveiling the therapeutic potential of 1,2,4-oxadiazole derivatives: An updated review
1,2,4-Oxadiazole derivatives, a prominent class of nitrogen-containing heterocycles, have gained considerable attention recently due to their broad spectrum of biological activities. This review focuses on the most recent developments (2018–2024) in the exploration of their therapeutic potential. Studies have highlighted the efficacy of 1,2,4-oxadiazole derivatives in multiple domains, including anticancer, antimicrobial, antidiabetic, anti-inflammatory, and neuroprotective applications. These compounds have demonstrated promising results, particularly in combating drug-resistant pathogens, managing metabolic disorders, and offering potential treatments for neurodegenerative diseases. With a growing body of research supporting their diverse biological roles, 1,2,4-oxadiazole derivatives continue to be a significant focus in drug discovery and development. This review compiles key findings from recent studies, offering insights into their therapeutic applications and potential future directions for research.
Authors
- Mustafa Jawad Kadham
- Amran M. AL-Erjan
- Raed Fanoukh Aboqader Al‐Aouadi
- L. Natrayan
- Stefan Bräse (ORCID: https://orcid.org/0000-0003-4845-3191)
- Hussam Elddin Nabeih Khasawneh
- Ali Abdulrazzaq Abdulhussein Alrikabi
- Roziyeva Muhayyo
- Hadeer M. Farhan (ORCID: https://orcid.org/0009-0005-2459-6843)
Institutions
- Karlsruhe Institute of Technology (DE)
- Thi Qar University (IQ)
- Iraqi University (IQ)
- Al-Balqa Applied University (JO)
- Al-Farahidi University
- National University of Uzbekistan (UZ)
- Saveetha University (IN)
- Minia University (EG)
Publication Details
- Journal
- Results in Chemistry
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1016/j.rechem.2025.102271
- Citations
- 2
- Primary Topic
- Synthesis and biological activity
- Type
- article
- Field-Weighted Citation Impact
- 1.87